2009, Número 2
<< Anterior Siguiente >>
Med Cutan Iber Lat Am 2009; 37 (2)
Doença crônica granulomatosa da face - relato de caso
Oyama Okajima, RM; D'Apparecida Santos Machado Filho, C; Pedreira Paixão, M; Mendonça de Barros, MI; Chmeliauskas Moya, M; Simões e Silva Enokihara, MM
Idioma: Portugués
Referencias bibliográficas: 12
Paginas: 90-93
Archivo PDF: 204.11 Kb.
FRAGMENTO
Sin resumen
REFERENCIAS (EN ESTE ARTÍCULO)
Scheuer MRV, Waal RIFV, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosácea-like syndrome and not granulomatous form of rosacea. Dermatology 2003; 206:120-3.
Uesugi Y, Aiba S, Usuba M, Tagami H. Oral prednisone in treatment of acne agminata. Br J Dermatol 1996;134:1098-100.
Darouti M, Zaher H. Lupus miliaris disseminatus faciei – pathology study of early, fully developed and late lesions. Int J Dermatol 1993;32: 508-11.
Bedlow AJ, Otter M, Marsden RA. Axillary acne agminata (lupus miliar disseminatus faciei). Cl Exp Dermatol 1998;23:125-8.
Skowron F, Causeret AS, Pabion C, Viallard AM, Balme B, Thomas L. F.I.G.U.R.E.: Facial Idiopathic GranUlomas with Regressive Evolution. Dermatology 2000;201:287-9.
Hodak E, Atrattner A, Feuerman H, Feinmesser M, David M. Lupus miliaris disseminatus faciei – the DNA of Mycobacterium tuberculosis is not detectable in active lesions by polymerase chain reaction. Br J Dermatol 1997;137:614-9.
Farrar CW, Bell HK, Dobson CM, Sharpe GR. Facial and axillary acne agminata. Br J Dermatol 2003;149:1076.
Ferrara G, Cannone M, Scalvenzi M, Delfino M, Staibano S, Rosa G, Barberis M. Facial granulomatous disease. Am J Dermatotopathol 2001;23:8-15.
Abulafia LA, Azulay D, Azulay R. In Azulay R, Azulay D. Dermatologia. 3.ed. Rio de Janeiro, Guanabara Koogan, 2004, pp. 156-161.
Moloney FJ, Egan CA. Clinicopathological cases. Cl Exp Dermatol 2003;28:685-6.
Weinberg JM. The anti-inflammatory effects of tetracyclines. Cutis 2005;75:6-11.
Melo FAF, Hijjar MA. I Consenso Brasileiro de Tuberculose. J Pneumol 1997;23:281-342.